Fitzgerald Kevin Joseph bought ALNY
March 2, 2026 · Form 4 insider transaction
Fitzgerald Kevin Joseph bought 8,105 shares of Alnylam Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,105
Price
$0.00
Total value
N/A
InsiderFitzgerald Kevin Joseph
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after8,105
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.